| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. A Patel, S MacMahon, J Chalmers, B Neal, L Billot, M Woodward, M Marre, ... | 9806* | 2008 |
| Intensive versus conventional glucose control in critically ill patients S Finfer, R Bellomi, D Blair, S Su, D Foster, V Dhingra, D Cook, P Dodek, ... | 5908 | 2009 |
| Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a … A Patel The Lancet 370 (9590), 829-840, 2007 | 3215 | 2007 |
| Hydroxyethyl starch or saline for fluid resuscitation in intensive care JA Myburgh, S Finfer, R Bellomo, L Billot, A Cass, D Gattas, P Glass, ... New England Journal of Medicine 367 (20), 1901-1911, 2012 | 2024 | 2012 |
| CPAP for prevention of cardiovascular events in obstructive sleep apnea RD McEvoy, NA Antic, E Heeley, Y Luo, Q Ou, X Zhang, O Mediano, ... New England Journal of Medicine 375 (10), 919-931, 2016 | 1956 | 2016 |
| Severe hypoglycemia and risks of vascular events and death S Zoungas, A Patel, J Chalmers, BE de Galan, Q Li, L Billot, M Woodward, ... New England Journal of Medicine 363 (15), 1410-1418, 2010 | 1741 | 2010 |
| Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage CS Anderson, E Heeley, Y Huang, J Wang, C Stapf, C Delcourt, R Lindley, ... New England Journal of Medicine 368 (25), 2355-2365, 2013 | 1656 | 2013 |
| Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial CS Anderson, Y Huang, JG Wang, H Arima, B Neal, B Peng, E Heeley, ... The Lancet Neurology 7 (5), 391-399, 2008 | 1136 | 2008 |
| Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ... New England Journal of Medicine, 2014 | 816 | 2014 |
| Adjunctive glucocorticoid therapy in patients with septic shock B Venkatesh, S Finfer, J Cohen, D Rajbhandari, Y Arabi, R Bellomo, ... New England Journal of Medicine 378 (9), 797-808, 2018 | 771 | 2018 |
| Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin Cardiovascular Assessment Study) KW Mahaffey, B Neal, V Perkovic, D de Zeeuw, G Fulcher, N Erondu, ... Circulation 137 (4), 323-334, 2018 | 540 | 2018 |
| Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes S Zoungas, M Woodward, Q Li, ME Cooper, P Hamet, S Harrap, S Heller, ... Diabetologia, 1-10, 2014 | 519 | 2014 |
| Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke CS Anderson, T Robinson, RI Lindley, H Arima, PM Lavados, TH Lee, ... New England Journal of Medicine, 2016 | 447 | 2016 |
| Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds S Zoungas, J Chalmers, T Ninomiya, Q Li, ME Cooper, S Colagiuri, ... Diabetologia 55 (3), 636-643, 2012 | 414 | 2012 |
| Intensive glucose control improves kidney outcomes in patients with type 2 diabetes V Perkovic, HL Heerspink, J Chalmers, M Woodward, M Jun, Q Li, ... Kidney international 83 (3), 517-523, 2013 | 382 | 2013 |
| Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage The Intensive Blood Pressure … CS Anderson, Y Huang, H Arima, E Heeley, C Skulina, MW Parsons, ... Stroke 41 (2), 307-312, 2010 | 348 | 2010 |
| Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials L Huang, K Trieu, S Yoshimura, B Neal, M Woodward, NRC Campbell, ... bmj 368, 2020 | 295 | 2020 |
| CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life MA Brown, GK Collett, EA Josland, C Foote, Q Li, FP Brennan Clinical Journal of the American Society of Nephrology 10 (2), 260-268, 2015 | 284 | 2015 |
| Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON MG Wong, V Perkovic, J Chalmers, M Woodward, Q Li, ME Cooper, ... Diabetes care 39 (5), 694-700, 2016 | 256 | 2016 |
| Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function: data from the CANVAS Program BL Neuen, T Ohkuma, B Neal, DR Matthews, D de Zeeuw, KW Mahaffey, ... Circulation 138 (15), 1537-1550, 2018 | 253 | 2018 |
